Cite
HARVARD Citation
Kassim, A. et al. (2014). The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease. Expert opinion on pharmacotherapy. pp. 325-336. [Online].